Truist Financial Corp Orasure Technologies Inc Transaction History

Truist Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$6.08 - $8.28 $407 - $554	-67 Reduced 0.13%	52,404 $322,000
Q4 2023 Feb 02, 2024	SELL	$5.13 - $8.35 $13,589 - $22,119	-2,649 Reduced 4.81%	52,471 $430,000
Q3 2023 Nov 14, 2023	BUY	$4.4 - $6.91 $242,528 - $380,879	55,120 New	55,120 $326,000
Q1 2019 Apr 23, 2019	SELL	$9.63 - $13.09 $101,432 - $137,876	-10,533 Closed	0 $0
Q4 2018 Jan 22, 2019	BUY	$10.53 - $15.54 $5,054 - $7,459	480 Added 4.77%	10,533 $123,000
Q4 2017 Jan 29, 2018	SELL	$13.44 - $22.81 $13,440 - $22,810	-1,000 Reduced 9.05%	10,053 $190,000
Q3 2017 Oct 23, 2017	BUY	$19.97 - $22.74 $220,728 - $251,345	11,053	11,053 $249,000

202

65.5M

2.2K

5.1K

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $282M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.